About the Pancreatic Cancer Research Map
The Pancreatic Cancer Research Map is a collaborative project of the National Cancer Institute, the Pancreatic Cancer Action Network (PanCAN), and the Lustgarten Foundation for Pancreatic Cancer Research. This unique mapping project is led by a Steering Committee composed of members of both organizations who are dedicated to connecting the dots between all researchers involved in pancreatic cancer research to speed the development of national strategies and to leverage resources for pancreatic cancer research. Plans are underway to add additional organizations interested in facilitating pancreatic research.
The Steering Committee
Chairpersons
Gloria Petersen, PhD - The Mayo Clinic
Elizabeth Thompson - Pancreatic Cancer Action Network (PanCAN)
Members
James L. Abbruzzese, MD - University of Texas MD Anderson Cancer Center
Ivan Ding, MD - National Cancer Institute
Julie Fleshman, JD, MBA - Pancreatic Cancer Action Network
Michael (Tony) Hollingsworth, PhD - Eppley Institute, University of Nebraska Medical Center
Kerri Kaplan - Lustgarten Foundation for Pancreatic Cancer Research
Gary Renshaw, DO - Johnson & Johnson
Lisa Stevens, PhD - National Cancer Institute
Cancer Map Partners
 |
The National Cancer Institute (NCI) is a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (DHHS) and is the Federal Government's principal agency for cancer research. Within the Office the NCI Director, the Office of Science Planning and Assessment (OSPA) is responsible to develop and coordinate NCI's scientific planning and evaluation activities. |
 |
The Pancreatic Cancer Action Network (PanCAN) is a national non-profit public-benefit advocacy organization that works to focus national attention on the need to find a cure for pancreatic cancer. It provides public and professional education, and highlights the urgent need for more research, effective treatments, prevention programs and early detection methods. |
 |
The Lustgarten Foundation for Pancreatic Cancer Research is a not-for-profit organization dedicated to advancing the diagnosis, treatment, cure and prevention of pancreatic cancer. Today, the Lustgarten Foundation is the nation's largest private supporter of pancreatic cancer research. In addition, the Foundation sponsors annual scientific conferences, manages a public awareness campaign featuring President Jimmy Carter and actor Matthew Modine, and distributes patient information at no cost to individuals and physicians. |
Participating Funding Organizations
 |
The American Cancer Society is a voluntary health organization dedicated to eliminating cancer as a major health problem through its community-based efforts within the United States, and by helping to develop cancer societies and strategic collaborations throughout the world. |
 |
The National Cancer Research Institute (NCRI) is an exciting new initiative that is challenging the way cancer research is carried out in the UK. For the first time the UK's major cancer research funding bodies from the government, charity and private sectors have come together to form a partnership as the NCRI with the purpose of accelerating and advancing cancer research for the benefit of patients and the UK cancer research community. |
 |
The Canadian Cancer Research Alliance (CCRA) is an alliance of cancer research funding organizations and affiliated partners working together to enhance the overall state of cancer research funding in Canada through improved communication, cooperation and coordination. CCRA is committed to planning a more effective pan-Canadian approach to cancer research which will utilize strategic partnerships to overcome some of the barriers to pursuing those major research programs which would truly transform the state of cancer research in Canada. |
